Advertisement
The Head of Diagnostic and Interventional Radiology at the Academic Hospital RoMed Clinic of Rosenheim in Germ...
An overview of technological improvements that may be expected in the next generation of thoracic endovascular...
A status report on thoracic endovascular aortic repair.
The Endovascular Today Buyer's Guide offers a searchable, comprehensive listing of the FDA-approved vascular interventional devices available in the United States.
The charts include sizes, configurations, and unique characteristics of each product, listed alphabetically by manufacturer name. You will also find links to download printable PDFs of each chart.
Vascular surgeon Sean P. Lyden, MD, discusses his role as the Medical Director for Clinical Supply Chain Manag...
A panel of interventional experts weighs in on how they would access and treat a series of challenging access ...
The Art of Vessel Access
Advertisement
Kalamazoo, MI - Full-time
Interventional Cardiology Fellowship
Phoenix, AZ - Full-time
New York, NY - Full-time
Tips and techniques for gaining access, as well as current options for closure. more >
The 2012 edition of the Buyer's Guide, your comprehensive resource for up-to-date information on current technologies for treating vascular disease. more >
Free classified listings for job opportunities in the vascular field, from clinical to industry positions.
Jobs Marketplace >
All of EVToday.com's news items and feature articles on thoracic aortic intervention in one convenient place.
Featured Channel: Thoracic >
Our annual Buyer's Guide is now available as an app for the iPad.
Click for your free download. >Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.